ஆஷர் உயிர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ஆஷர் உயிர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ஆஷர் உயிர் Today - Breaking & Trending Today
23 Most Promising Healthcare Startups of 2021, According to Top VCs businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.
MedCity News Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials Vaccitech and Werewolf Therapeutics joined the public markets, raising a combined $230 million. The vaccine developer and the cancer immunotherapy biotech will apply the IPO proceeds toward clinical development of their respective pipelines. Shares0
Two more biotech companies are joining the public markets. Werewolf Therapeutics and Vaccitech priced their respective IPOs late Thursday, raising a combined $230 million for multiple clinical trials. Werewolf was able to boost the size of its deal, selling 7.5 million shares, up from the 6.25 million shares that it had initially planned to offer. Those shares were priced at $16 each, right at the midpoint of the biotech’s projected price range, and the company was able to gross $120 million. Werewolf’s shares will trade on the Nasdaq under the stock symbol “HOWL.” ....
April 1, 2021 By Bio-IT World Staff April 1, 2021 | New investment funds for late-stage companies and public health. Next-gen genomic medicines and single-cell multiomics get cash, and PatientsLikeMe raises a new round of funding to expand.
$969M Investment Fund for Early to Late-Stage Companies Foresite Capital, a multi-stage healthcare and life sciences investment firm, has announced its fifth and largest fundraise with $969 million in capital commitments, significantly oversubscribed above its original target. The offering comprises Foresite Capital Fund V, L.P. and Foresite Capital Opportunity Fund V, L.P. With these new funds, Foresite Capital is investing in emerging healthcare and life sciences companies at all stages that are solving some of the biggest inefficiencies and pain points of the $10 trillion global healthcare market. Foresite Capital now has ~$4 billion in assets under management. Press release. ....
Explora BioLabs to Open Its First East Coast Facility in Boston Turnkey research facility opens to local biotechs beginning mid-2021 News provided by Share this article Share this article BOSTON, Jan. 7, 2021 /PRNewswire/ Explora BioLabs, the nation s largest provider of pre-clinical vivarium, husbandry, and research space, will launch its first East Coast facility here in mid-2021. The new Explora facility will provide the Boston biotech sector with a fully managed, off-site research facility with access to crucial adjacent preclinical services and professional staff to support client research. The space will allow researchers to focus on their work while Explora handles all of the in vivo management, logistics, and compliance requirements. Explora s facilities feature state-of-the-art equipment and operations, such as an onsite IVIS Lumina II imager and a dedicated cell culture room, which are validated through AAALAC accreditation, NIH/OLAW assurance, ....